background
microbi
etiolog
communityacquir
pneumonia
cap
still
well
character
past
year
polymeras
chain
reaction
pcr
base
method
develop
mani
pathogen
caus
respiratori
tract
infect
aim
studi
determin
etiolog
cap
among
adultsespeci
occurr
mix
infect
among
patient
capbi
implement
new
diagnost
pcr
platform
combin
convent
method
method
adult
admit
karolinska
univers
hospit
studi
prospect
period
microbiolog
test
method
includ
cultur
blood
sputum
nasopharyng
secret
sampl
sputum
sampl
analyz
realtim
quantit
pcr
streptococcu
pneumonia
haemophilu
influenza
moraxella
catarrhali
nasopharyng
specimen
analyz
use
pcr
serolog
test
mycoplasma
pneumonia
chlamydophila
pneumonia
virus
common
respiratori
tract
urin
antigen
assay
detect
pneumococc
legionella
pneumophila
antigen
microbi
etiolog
could
identifi
patient
patient
complet
n
p
sampl
microbiolog
agent
identifi
case
frequent
detect
pathogen
pneumonia
patient
respiratori
viru
patient
two
pathogen
present
case
determin
etiolog
conclus
supplement
tradit
diagnost
method
new
pcrbase
method
high
microbi
yield
achiev
especi
evid
patient
complet
sampl
mix
infect
frequent
commonli
pneumonia
togeth
respiratori
viru
knowledg
pathogen
caus
communityacquir
pneumonia
cap
constitut
basi
select
empir
antimicrobi
treatment
substanti
impact
prognosi
patient
despit
develop
improv
microbiolog
method
past
year
etiolog
cap
still
well
character
recent
studi
wellcharacter
patient
group
appropri
specimen
collect
prior
antibiot
treatment
combin
bacteriolog
virolog
diagnost
publish
virus
recogn
import
caus
cap
among
infant
children
role
virus
play
caus
cap
among
adult
well
understood
recent
studi
base
molecular
diagnost
indic
viral
etiolog
cap
may
underestim
previou
limit
rang
diagnost
method
still
unclear
whether
viru
caus
pneumonia
whether
viru
act
conjunct
respiratori
pathogen
previou
studi
shown
respiratori
virus
capabl
invad
replic
lower
respiratori
tract
mucosa
moreov
report
indic
incid
mix
infect
may
signific
among
patient
admit
hospit
cap
nucleic
acid
detect
use
realtim
polymeras
chain
reaction
pcr
develop
mani
bacteri
viral
pathogen
caus
respiratori
tract
infect
one
advantag
molecular
diagnost
possibl
identifi
pathogen
patient
alreadi
receiv
antibiot
treatment
knowledg
new
pcr
method
evalu
concurr
prospect
studi
patient
cap
aim
studi
determin
etiolog
cap
among
patient
admit
hospit
particular
assess
occurr
mix
infect
implement
new
diagnost
pcr
platform
combin
convent
method
patient
popul
inclus
criteria
describ
detail
elsewher
period
year
consecut
patient
cap
admit
depart
infecti
diseas
karolinska
univers
hospit
solna
stockholm
sweden
includ
prospect
studi
n
p
patient
provid
written
inform
consent
studi
approv
region
ethic
committe
stockholm
sweden
specimen
collect
nasopharyng
secret
sputum
blood
obtain
bacteri
cultur
start
antibiot
therapi
emerg
depart
often
difficult
obtain
good
qualiti
sputum
sampl
emerg
depart
induc
sputum
specimen
obtain
assist
respiratori
physiotherapist
ward
nasopharyng
secret
sampl
bacteri
viral
detect
urin
sampl
pneumococc
legionella
pneumophila
antigen
detect
obtain
day
hospit
admiss
blood
sampl
obtain
day
hospit
admiss
week
later
serolog
analysi
influenza
viru
parainfluenza
viru
adenoviru
respiratori
syncyti
viru
rsv
mycoplasma
pneumonia
chlamydophila
pneumonia
microbiolog
method
regard
bacteriolog
method
sputum
sampl
examin
microscopi
sampl
contain
preponder
leukocyt
squamou
epitheli
cell
consid
accept
cultur
accord
accept
criteria
read
cultur
plate
tri
especi
recov
identifi
bacteria
indic
purul
part
slide
number
colonyform
unit
per
millilit
cfuml
assess
use
semiquantit
techniqu
quantit
cultur
sputum
sampl
qualit
cultur
nasopharyng
sampl
well
blood
sampl
perform
accord
accept
method
criteria
realtim
quantit
pcr
rqpcr
target
pneumolysin
pli
gene
streptococcu
pneumonia
fumar
reductas
frdb
gene
haemophilu
influenza
outer
membran
protein
copb
gene
moraxella
catarrhali
perform
describ
kai
et
al
respiratori
tract
sampl
also
examin
l
pneumophila
use
cultur
andor
pcr
pneumonia
c
pneumonia
use
pcr
immunochromatograph
membran
test
binaxnow
pneumonia
binaxnow
legionella
inver
medic
innov
perform
urin
sampl
detect
pneumococc
l
pneumophila
antigen
commerci
avail
enzymelink
immunosorb
assay
ani
labsystem
use
accord
manufactur
instruct
detect
immunoglobulin
g
igg
igm
antibodi
pneumonia
c
pneumonia
regard
virolog
method
viru
isol
perform
nasopharyng
secret
sampl
accord
diagnost
practic
detect
adenoviru
enteroviru
human
bocaviru
human
coronavirus
human
metapneumoviru
influenza
virus
b
parainfluenza
virus
rhinoviru
rsv
b
perform
retrospect
newli
develop
realtim
pcr
platform
three
reaction
duplex
assay
parainfluenza
viru
parainfluenza
viru
human
coronaviru
rsv
rsv
b
although
report
rsv
reaction
perform
singleag
assay
serolog
inhous
enzymelink
immunosorb
assay
use
detect
igg
antibodi
adenoviru
use
adenoviru
type
antigen
consid
react
adenovirus
influenza
b
virus
parainfluenza
virus
rsv
diagnost
criteria
microorgan
consid
definit
etiolog
signific
cultur
blood
pleural
fluid
protect
specimen
brush
cutoff
cfuml
protect
specimen
brush
broth
bronchoalveolar
lavag
cutoff
cfuml
bronchoalveolar
lavag
fluid
urin
antigen
assay
pneumonia
l
pneumophila
posit
detect
l
pneumophila
cultur
andor
pcr
sputum
also
consid
definit
support
etiolog
accord
previou
find
patient
bacterem
pneumococc
pneumonia
identif
cfuml
pneumonia
sputum
cultur
nasopharyng
cultur
accept
probabl
signific
pneumococc
dna
correspond
cfuml
use
rqpcr
also
consid
probabl
signific
bacteria
identif
cfuml
sputum
cultur
dna
correspond
cfuml
use
rqpcr
h
influenza
catarrhali
consid
probabl
signific
identif
pneumonia
c
pneumonia
use
pcr
presenc
igm
antibodi
increas
igg
acut
convalesc
phase
sampl
consid
support
probabl
microbi
diagnosi
viral
etiolog
deem
probabl
least
one
follow
criteria
met
detect
viru
respiratori
secret
sampl
use
isol
pcr
increas
igg
titer
acut
convalesc
phase
sampl
baselin
characterist
patient
shown
tabl
studi
popul
consist
male
femal
mean
age
year
rang
year
total
patient
least
underli
diseas
malign
frequent
averag
stay
hospit
day
rang
day
hospit
admiss
patient
alreadi
start
antibiot
therapi
microbiolog
etiolog
cap
definit
probabl
microbi
etiolog
cap
establish
patient
rqpcr
assay
pneumonia
h
influenza
catarrhali
sputum
sampl
pcr
platform
respiratori
virus
ad
convent
method
contrast
microbi
yield
patient
convent
method
use
bacteri
etiolog
found
patient
bacteri
speci
identifi
tabl
blood
cultur
provid
microbi
diagnosi
patient
pneumonia
detect
urinari
antigen
assay
patient
test
seventeen
patient
also
diagnos
use
blood
cultur
wherea
patient
diagnos
use
urinari
antigen
test
alon
tabl
probabl
diagnosi
establish
sputum
cultur
patient
increas
diagnost
yield
addit
case
posit
find
sputum
rqpcr
pneumonia
h
influenza
catarrhali
obtain
patient
patient
test
posit
pneumonia
h
influenza
increas
diagnost
yield
addit
case
pneumonia
found
nasopharyng
secret
sampl
patient
increas
microbi
diagnost
yield
well
diagnost
yield
method
addit
case
diagnost
yield
differ
viral
diagnost
method
eight
case
detect
viral
isol
serolog
account
posit
find
case
influenza
parainfluenza
viru
pcr
result
nasopharyng
secret
sampl
patient
posit
patient
also
serum
sampl
test
posit
influenza
viru
common
find
ie
patient
tabl
nine
differ
viral
agent
identifi
mix
infect
convent
diagnost
method
identifi
potenti
pathogen
patient
pathogen
patient
pcr
test
pneumonia
h
influenza
catarrhali
respiratori
virus
increas
total
diagnost
yield
patient
pathogen
respect
patient
definit
probabl
bacteri
etiolog
present
mix
infect
pneumonia
identifi
copathogen
found
sampl
patient
bacteri
pathogen
isol
h
influenza
viral
agent
isol
influenza
viru
isol
rhinoviru
patient
document
viral
find
twothird
ie
patient
least
addit
pathogen
identifi
pneumonia
isol
microbiolog
yield
differ
method
among
patient
complet
sampl
collect
total
patient
complet
sampl
collect
blood
sputum
nasopharyng
secret
sampl
cultur
sputum
sampl
analyz
rqpcr
pneumonia
h
influenza
catarrhali
nasopharyng
specimen
analyz
use
pcr
serolog
test
pneumonia
c
pneumonia
virus
common
respiratori
tract
urin
antigen
assay
detect
pneumococc
l
pneumophila
antigen
patient
test
posit
chlamydophila
pneumonia
patient
test
posit
mycoplasma
pneumonia
note
date
patient
receiv
diagnosi
use
particular
method
unless
otherwis
indic
addit
patient
receiv
diagnosi
use
differ
method
exampl
addit
case
influenza
viru
diagnos
serolog
diagnos
viru
isol
anoth
case
diagnos
polymeras
chain
reaction
pcr
nasopharyng
secret
sampl
diagnos
viru
isol
serolog
none
patient
given
antibiot
admiss
hospit
figur
accord
diagnost
criteria
microbi
etiolog
establish
patient
multipl
pathogen
detect
sampl
patient
patient
receiv
diagnosi
bacteri
infect
patient
pneumonia
common
bacteri
find
second
microbi
agent
found
patient
patient
respiratori
viru
infect
total
patient
receiv
diagnosi
viral
infect
patient
bacteri
pathogen
predominantli
pneumonia
also
found
treatment
intens
care
unit
mortal
patient
treat
intens
care
unit
etiolog
agent
found
sampl
patient
multipl
pathogen
detect
sampl
patient
eight
patient
pneumonia
infect
patient
least
viral
agent
also
detect
patient
sampl
streptococcu
pyogen
found
togeth
metapneumoviru
anoth
patient
sampl
pneumonia
identifi
overal
case
fatal
rate
ie
patient
die
microbi
infect
diagnos
patient
die
pneumonia
rsv
found
sampl
first
patient
die
pyogen
metapneumoviru
sampl
second
patient
die
catarrhali
sampl
third
patient
die
three
major
find
report
studi
first
total
microbi
yield
high
yield
improv
implement
pcr
respiratori
viru
rqpcr
pneumonia
h
influenza
catarrhali
second
pneumonia
lead
caus
agent
third
respiratori
virus
found
often
high
frequenc
part
mix
infect
usual
combin
pneumonia
establish
microbi
diagnosi
patient
cap
challeng
although
mani
etiolog
studi
perform
etiolog
often
remain
unknown
approxim
onehalf
case
present
studi
least
etiolog
agent
found
twothird
case
yield
increas
patient
complet
sampl
collect
antibiot
given
prior
hospit
admiss
yield
improv
ad
convent
procedur
rqpcr
test
sputum
sampl
pneumonia
h
influenza
catarrhali
realtim
pcr
test
nasopharyng
secret
sampl
respiratori
virus
blood
sampl
cultur
easi
collect
provid
definit
microbi
diagnosi
result
posit
present
studi
reveal
etiolog
infect
patient
number
similar
previou
studi
urin
specimen
also
easi
obtain
pneumococc
l
pneumophila
antigen
assay
gener
consid
specif
howev
test
provid
diagnosi
addit
patient
ie
nonbacterem
case
pneumococc
antigen
assay
perform
patient
pneumococc
infect
specimen
posit
bacterem
patient
nonbacterem
patient
onethird
patient
test
posit
sputum
sampl
posit
pneumonia
studi
alon
result
indic
sensit
pneumococc
urin
antigen
assay
may
lower
recent
report
sputum
sampl
cultur
rqpcr
obtain
patient
sputum
sampl
cultur
provid
probabl
etiolog
onefourth
patient
sputum
sampl
rqpcr
provid
probabl
etiolog
onethird
patient
furthermor
patient
neg
test
result
cultur
blood
sputum
urin
antigen
assay
rqpcr
provid
probabl
microbi
diagnosi
case
confirm
method
valuabl
complement
convent
method
pli
gene
use
rqpcr
recent
identifi
streptococcu
miti
well
thu
specif
analysi
may
question
howev
analysi
quantit
amount
dna
miti
would
probabl
low
moreov
previou
data
support
good
specif
neg
result
throat
sampl
posit
find
determin
use
diagnost
method
howev
futur
studi
import
take
account
choic
primer
pneumonia
common
microorgan
found
patient
approxim
twothird
patient
complet
diagnost
sampl
collect
support
pneumococc
etiolog
find
support
earlier
suggest
pneumococci
caus
major
cap
case
neg
test
result
found
use
convent
method
virus
common
pathogen
found
sampl
obtain
young
children
cap
account
case
contrast
viral
etiolog
previous
report
adult
patient
cap
admit
hospit
howev
recent
public
viral
agent
recogn
common
caus
cap
among
adult
result
present
studi
corrobor
find
support
viral
etiolog
onethird
patient
new
realtim
pcr
platform
provid
viral
diagnosi
patient
test
addit
method
convent
microbi
techniqu
improv
yield
nearli
result
agreement
previou
find
oosterheert
et
al
indic
pcr
rapid
viru
isol
serolog
also
sensit
role
virus
play
caus
cap
fulli
elucid
particular
possibl
rhinoviru
may
caus
cap
still
consid
controversi
howev
recent
studi
establish
rhinoviru
replic
occur
lower
airway
infect
human
respiratori
epitheli
cell
line
vitro
induc
releas
proinflammatori
cytokin
chemokin
clinic
report
rhinoviru
also
associ
lower
respiratori
tract
diseas
includ
pneumonia
among
adult
recent
review
preval
respiratori
viral
find
asymptomat
subject
definit
conclus
could
drawn
lack
prospect
studi
howev
avail
report
suggest
preval
infrequ
overal
persist
viral
nucleic
acid
rather
short
last
indic
viral
find
present
studi
clinic
relev
mix
infect
among
patient
admit
hospit
cap
previous
report
account
case
cap
compar
case
found
present
studi
convent
method
consid
howev
pcr
result
ad
mix
infect
found
sampl
onethird
patient
determin
etiolog
well
sampl
patient
complet
sampl
data
agreement
recent
studi
lim
et
al
found
second
pathogen
sampl
patient
pneumococc
infect
patient
viral
agent
studi
pneumonia
common
bacteri
agent
mix
infect
copathogen
found
onehalf
case
major
pathogen
ie
viral
agent
thu
viral
agent
adult
cap
often
seem
part
mix
infect
usual
pneumonia
copathogen
also
patient
sever
pneumonia
pneumonia
predomin
pathogen
copathogen
frequent
found
viral
agent
sever
limit
studi
first
patient
met
criteria
inclus
enrol
studi
second
sampl
collect
complet
issu
inher
trial
enrol
patient
cap
reason
believ
group
patient
includ
would
substanti
differ
group
patient
studi
also
sampl
obtain
emerg
depart
decid
physician
call
patient
ward
later
includ
studi
investig
select
bia
collect
sampl
possibl
unlik
summari
supplement
tradit
diagnost
method
new
pcrbase
techniqu
common
bacteria
number
respiratori
viral
agent
higher
microbi
yield
achiev
pneumonia
lead
caus
agent
account
onehalf
case
determin
etiolog
mix
infect
frequent
combin
pneumonia
respiratori
viru
common
find
